06/11/2025
8:01 PM | Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2025
3:19 PM | Detheux Michel (Reporting)
iTeos Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2025
8:03 PM | Hallal David (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
8:03 PM | Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2025
4:16 PM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/05/2025
4:25 PM | iTeos Therapeutics (Filer)
| Form DEFA14A | |
06/04/2025
3:00 PM | iTeos Therapeutics (Subject)
Ridgeback Capital Investments L.P. (Filed by)
| Form SCHEDULE 13G | |
06/04/2025
3:03 PM | Hallal David (Reporting)
iTeos Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2025
3:03 PM | Detheux Michel (Reporting)
iTeos Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2025
7:42 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2025
4:46 PM | iTeos Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
Get the Latest News and Ratings for ITOS and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for iTeos Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
05/16/2025
6:22 PM | EcoR1 Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SCHEDULE 13D | |
05/16/2025
5:52 PM | EcoR1 Capital, LLC (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
4:30 PM | iTeos Therapeutics (Subject)
MPM BioVentures 2014, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
05/15/2025
4:32 PM | EVNIN LUKE (Reporting)
Foley Todd (Reporting)
iTeos Therapeutics (Issuer)
MPM Asset Management Investors BV2014 LLC (Reporting)
MPM ASSET MANAGEMENT INVESTORS BV2018 LLC (Reporting)
MPM BioVentures 2014 GP LLC (Reporting)
MPM BioVentures 2014 LLC (Reporting)
MPM BioVentures 2014, L.P. (Reporting)
MPM BIOVENTURES 2018 , L.P. (0001729504) (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
4:33 PM | iTeos Therapeutics (Issuer)
MPM BioVentures 2018 GP LLC (Reporting)
MPM BioVentures 2018 LLC (Reporting)
MPM BIOVENTURES 2018, L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2025
4:34 PM | GADICKE ANSBERT (Reporting)
iTeos Therapeutics (Issuer)
MPM BioImpact LLC (Reporting)
Oncology Impact Fund Management L.P. (0001721036) (Reporting)
UBS Oncology Impact Fund L.P. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
7:00 PM | iTeos Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/14/2025
5:34 PM | iTeos Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
| Form SCHEDULE 13D/A | |
05/13/2025
6:09 PM | EcoR1 Capital, LLC (Reporting)
iTeos Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/13/2025
6:10 PM | EcoR1 Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
05/13/2025
6:56 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2025
6:43 PM | EcoR1 Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SCHEDULE 13G | |
04/28/2025
3:36 PM | iTeos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/24/2025
6:17 AM | iTeos Therapeutics (Filer)
| Form ARS | |
04/24/2025
6:07 AM | iTeos Therapeutics (Filer)
| Form DEF 14A | |
04/24/2025
6:12 AM | iTeos Therapeutics (Filer)
| Form DEFA14A | |
04/23/2025
7:57 PM | BlackRock, Inc. (Filed by)
iTeos Therapeutics (Subject)
| Form SCHEDULE 13G/A | |
04/15/2025
4:04 PM | BlackRock Portfolio Management LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SCHEDULE 13G | |
03/11/2025
7:00 PM | Call Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | iTeos Therapeutics (Issuer)
McGrath Yvonne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/11/2025
7:00 PM | Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/05/2025
6:06 AM | iTeos Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/05/2025
6:14 AM | iTeos Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/13/2025
6:10 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
5:00 PM | Feltquate David (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2024
7:27 PM | BIOTECHNOLOGY VALUE FUND L P (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13G | |
11/19/2024
6:59 PM | Gall Matthew (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:57 AM | Boxer Capital Management, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
11/18/2024
8:57 PM | Boxer Capital Management, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
New Rule Hits in July — The Smart Money Already Moved (Ad) A little-known regulation quietly goes into effect this July.
And it's already being exploited by Wall Street and the Big Banks…
It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash.
Not stocks. Not real estate. And definitely not the U.S. dollar.
We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them. To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how |
11/14/2024
5:04 PM | EcoR1 Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13G/A | |
11/12/2024
6:08 AM | iTeos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/04/2024
6:00 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
8:49 PM | Boxer Capital, LLC (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
10/15/2024
6:20 PM | Boxer Asset Management Inc. (Filed by)
iTeos Therapeutics (Subject)
| Form SC 13D/A | |
09/30/2024
8:00 AM | iTeos Therapeutics (Subject)
TANG CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G | |
09/16/2024
6:00 AM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2024
7:00 PM | Detheux Michel (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2024
6:08 AM | iTeos Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/05/2024
6:16 AM | Feltquate David (Reporting)
iTeos Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/05/2024
6:19 AM | Feltquate David (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | Iannone Robert (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | iTeos Therapeutics (Issuer)
RHOADS ANN D (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | DeSimone Jill (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | Hallal David (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | Davis Aaron I. (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | iTeos Therapeutics (Issuer)
Lee David K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | iTeos Therapeutics (Issuer)
Van Hauwermeiren Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
7:00 PM | Ho Tony W (Reporting)
iTeos Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
3:01 PM | iTeos Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy ITOS Stock Free ITOS Stock Alerts